These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6354615)

  • 1. Should vitiligo be treated?
    Grimes PE; Kenney JA
    Cutis; 1983 Oct; 32(4):343-4, 346. PubMed ID: 6354615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussion of a case of vitiligo.
    Lerner MR; Fitzpatrick TB; Halder RM; Hawk JL
    Photodermatol Photoimmunol Photomed; 1999 Feb; 15(1):41-4. PubMed ID: 9990671
    [No Abstract]   [Full Text] [Related]  

  • 4. How we treat vitiligo.
    Kenney JA; Grimes PE
    Cutis; 1983 Oct; 32(4):347-8. PubMed ID: 6627994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of vitiligo].
    Frenk E
    Hautarzt; 1986 Jan; 37(1):1-5. PubMed ID: 3949507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical PUVA therapy for vitiligo.
    Halder RM
    Dermatol Nurs; 1991 Jun; 3(3):178-80, 198. PubMed ID: 1828681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad.
    Mashayekhi V; Javidi Z; Kiafar B; Manteghi AA; Saadatian V; Esmaeili HA; Hosseinalizadeh S
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827019
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern treatment approaches to vitiligo.
    Plott RT; Wagner RF
    Cutis; 1990 May; 45(5):311-6. PubMed ID: 2192829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study.
    Singh S; Khandpur S; Sharma VK; Ramam M
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1344-51. PubMed ID: 23066663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non PUVA nonsurgical therapies for vitiligo.
    Mandel AS; Haberman HF; Pawlowski D; Goldstein E
    Clin Dermatol; 1997; 15(6):907-19. PubMed ID: 9404694
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond Traditional Treatment: The Importance of Psychosocial Therapy in Vitiligo.
    Rzepecki AK; McLellan BN; Elbuluk N
    J Drugs Dermatol; 2018 Jun; 17(6):688-691. PubMed ID: 29879259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo: current medical and scientific understanding.
    Boissy RE; Nordlund JJ
    G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of extensive vitiligo.
    Wee TA
    Hawaii Med J; 1997 Feb; 56(2):37-40. PubMed ID: 9063009
    [No Abstract]   [Full Text] [Related]  

  • 14. Advanced treatment modalities for vitiligo.
    Patel NS; Paghdal KV; Cohen GF
    Dermatol Surg; 2012 Mar; 38(3):381-91. PubMed ID: 22288899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the combination of calcipotriol and PUVA effective in vitiligo?
    Baysal V; Yildirim M; Erel A; Kesici D
    J Eur Acad Dermatol Venereol; 2003 May; 17(3):299-302. PubMed ID: 12702070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUVA treatment of vitiligo: a retrospective study of 59 patients.
    Wildfang IL; Jacobsen FK; Thestrup-Pedersen K
    Acta Derm Venereol; 1992 Aug; 72(4):305-6. PubMed ID: 1357897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome.
    Parsad D; Pandhi R; Dogra S; Kanwar AJ; Kumar B
    Br J Dermatol; 2003 Feb; 148(2):373-4. PubMed ID: 12588405
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of vitiligo in children.Symposium.
    Grimes PE; Kelly AP; Cline DJ; Nordlund JJ; Jareatt MT; Rogers M; Treadwell PA; Burgdorf WH; Kenney JA
    Pediatr Dermatol; 1986 Dec; 3(6):498-510. PubMed ID: 3562364
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial effects of vitiligo.
    Ongenae K; Beelaert L; van Geel N; Naeyaert JM
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):1-8. PubMed ID: 16405601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.